Showing results (691-700 of 713) with videos related to
Sort By:
Pageof 72
The Journal of Urology|November 3, 2015
Age, Gender and R.E.N.A.L. Nephrometry Score do not Improve the Accuracy of a Risk Stratification Algorithm Based on Biopsy and Mass Size for Assigning Surveillance versus Treatment of Renal TumorsTakahiro Osawa, Khaled S Hafez, David C Miller, et al.Clinical Chemistry|December 22, 2009
IgG antibodies against deamidated gliadin peptides for diagnosis of celiac disease in patients with IgA deficiencyDanilo Villalta, Elio Tonutti, Christian Prause, et al.Australian Journal of Primary Health|January 7, 2024
A systematic search and narrative review of Aboriginal and Torres Strait Islander women and men pelvic health care: demonstrated need for improvementEmma M Wise, Marilyn A Morgan, Emily D Biggs, et al.Anesthesiology|November 18, 2021
Prolonged Blood Storage and Risk of Posttransfusion Acute Kidney InjuryJanet Adegboye, Suneeti Sapatnekar, Edward J Mascha, et al.Nanotechnology|December 8, 2010
Fe:O:C grown by focused-electron-beam-induced deposition: magnetic and electric propertiesR Lavrijsen, R Córdoba, F J Schoenaker, et al.Radiology|September 12, 2018
Gadolinium Retention: A Research Roadmap from the 2018 NIH/ACR/RSNA Workshop on Gadolinium ChelatesRobert J McDonald, Deborah Levine, Jeffrey Weinreb, et al.Journal of the American College of Radiology : JACR|June 25, 2016
"Concordance" Revisited: A Multispecialty Appraisal of "Concordant" Preliminary Abdominopelvic CT ReportsJordan M Brown, Elliot C Dickerson, Lee C Rabinowitz, et al.The Journal of Thoracic and Cardiovascular Surgery|December 3, 2014
Oxidant stress regulatory genetic variation in recipients and donors contributes to risk of primary graft dysfunction after lung transplantationEdward Cantu, Rupal J Shah, Wei Lin, et al.Frontiers in Surgery|January 14, 2022
Management of Nephrolithiasis in Pregnancy: Multi-Disciplinary Guidelines From an Academic Medical CenterMatthew S Lee, Michael A Fenstermaker, Emily E Naoum, et al.Lung Cancer (Amsterdam, Netherlands)|June 16, 2019
First-line afatinib for advanced EGFRm+ NSCLC: Analysis of long-term responders in the LUX-Lung 3, 6, and 7 trialsMartin Schuler, Luis Paz-Ares, Lecia V Sequist, et al.Pageof 72